HUBBARD, Ohio, Jan. 8 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX), a nano-biotechnology company is pleased to announce that the company has been named "Stock Pick of January 2008" by Stockprowler (http://www.stockprowler.com). Dana Allen, NanoLogix vice president, stated that "This is another example of our company getting increased attention from the investment community. We are happy to be selected by Stockprowler -- an independent stock scouting service who came to their decision through public research and one that receives no compensation from the companies they profile."
About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has 31 granted Patents and 36 Patents Pending for bioreactor-based Hydrogen Production, revolutionary rapid medical testing technologies, potential treatments for sepsis and cancer (via apoptosis), and bioremediation. Information on NanoLogix is available at http://www.nanologixinc.com.
This press release contains statements, which may constitute
"forward-looking statements" within the meaning of the Securities Act of
1933 and the Securities Exchange Act of 1934, as amended by the Private
Securities Litigation Reform Act of 1995. Those statements include
statements regarding the intent, belief or current expectations of
NanoLogix, Inc., and members of its management as well as the assumptions
on which such statements are based. Prospective investors are cautioned
that any such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual results
may differ materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or revise
forward-looking statements to reflect
|SOURCE NanoLogix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved